Firstly, the spontaneous reporting system is affected by limitations within the FAERS database, including duplicate reports, reporting accuracy and quality, incomplete or insufficient details regarding drug administration (such as site, route, dose and timing), and the lack of important patient characteristics (such as medical history and comorbidities)
But it hasnt been demonstrated, says Blundell, who is working with a food company to develop foods that are more palatable for people on GLP-1 medications
Touching the Cleaned Area After cleaning the skin, avoid touching the intended injection site with your fingers before inserting the needle
This product is intended to be handled solely by licensed and qualified professionals
Furthermore, its short half-life of less than 3 h (Min et al., 2025) necessitates twice-daily injections to maintain efficacy, which can be a limiting factor for long-term patient adherence
In recent years, a number of drugs have emerged that have significant cardio-renal protective effects in patients with diabetes, and a typical example is sodium-glucose cotransporter 2 inhibitor (SGLT2i), glucagon-like peptide-1 receptor agonist (GLP-1RA), and nonsteroidal mineralocorticoid receptor antagonist, finerenone